NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances

NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales IdeaSphere Obtains Exclusive Worldwide License to Weil Nutritional Supplements Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada). IdeaSphere Obtains Exclusive Worldwide License to Weil Nutritional Supplements Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada). IdeaSphere Obtains Exclusive Worldwide License to Weil Nutritional Supplements Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada). IdeaSphere Obtains Exclusive Worldwide License to Weil Nutritional Supplements Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada). IdeaSphere Obtains Exclusive Worldwide License to Weil Nutritional Supplements Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada). IdeaSphere Obtains Exclusive Worldwide License to Weil Nutritional Supplements Company announces that it has reached an agreement in principle with Weil Lifestyle to assume exclusive, worldwide licensing rights to Weil Nutritional Supplements (exclusing Canada). Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. New Study Finds Cranberry Compounds Block Cancer New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro. Lipid Nutrition Acquires PharmaNutrients’ CLA One Business Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006. Lipid Nutrition Acquires PharmaNutrients’ CLA One Business Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006. Lipid Nutrition Acquires PharmaNutrients’ CLA One Business Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006. Karen Weaver Joins Epstein Becker & Green, P.C. Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG). Karen Weaver Joins Epstein Becker & Green, P.C. Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG). Karen Weaver Joins Epstein Becker & Green, P.C. Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG). Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Zuellig Appoints George Pontiakos President and CEO of North American Operations Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. Unigen Pharmaceuticals Hires Director of Clinical Research Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D. MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million. MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million. MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients. Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program. Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program. Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program. Jarrow Industries, Inc. Achieves International Good Manufacturing Practices (GMP) Registration Company has announced that it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program. CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing. CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing. CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing. HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism' Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America. HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism' Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America. HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism' Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America. HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism' Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America. HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism' Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	The Natural Health Product Research Society of Canada (NHPRS) is issuing a reminder that the deadline for early bird registration for the the 3rd Annual Research Conference and Tradeshow 'From Concept to Consumer' will end Tuesday January 31st 2006. The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers. Regiustration information is available at: http://www.nhpresearch.bcit.ca/Toronto2006.html#Registration This annual conference is the premiere NHP scientific event in North America, showcasing the year’s best original research and providing a critically needed forum for dialogue amongst NHP research stakeholders. The high quality program has drawn strong support from the bio-medical community and industry leaders dedicated to evidence-based products. As a result of overwhelming success in previous meetings, an estimated 400 people will attend the 2006 conference. The core audience of scientists from academia, industry and government, will be joined by a diversity of companies, health professionals, and regulators involved or interested in NHP research, products, and services. "I have attended hundreds of conferences in the natural products industry and regard the NHPRS annual conference to be a must-attend event," observes Loren Israelsen, Executive Director, Utah Natural Products Alliance (UNPA) "The relevance and quality of presentations are almost without peer. There is no other venue where so many government, academic, agricultural and industry experts come together to exchange news and envision a better, more practical world for natural health products -- and the food is always terrific." The Program: The “From Concept to Consumer” program will feature an impressive line-up of invited speakers complementing the 60 peer-reviewed research papers. Speakers: Dr. S. Boyd Eaton, distinguished scientist and author of the Paleolithic Prescription, will give the opening plenary lecture. The world’s foremost authority on NHP toxicology, Dr. Francis Brinker will present the Saturday keynote speech on food-NHP-drug interactions, and the clinical relevance of in vitro research. The evolving scientific evidence requirements along food-NHP spectrum will be examined in special plenary symposia with invited lectures from Jim Kaput (Nutragenomics), Loren Israelsen (UNPA), Beth Yetley (ODS), John Cardellina (NIH), Barbara Schneeman (CFSAN), Steve Dentali (AHPA), Marguerite Klein (NCCAM), Ron Doering, and Bruce Holub. The closing plenary lecture will be delivered by Europe’s grand master of NHP research, Dr. Ezio Bombardelli, the President of the Scientific Board at Indena, the world’s largest producer of standardized botanical extracts in Milan, Italy. The conference will also feature healthful gourmet food, elegant social events, and an intimate trade show limited to companies supporting rigorous NHP research. The opening reception will provide networking opportunities enhanced by a live jazz quartet and tantalizing canapes. Following cocktails and an epicurean banquet accompanied by a harpist, the gala evening will conclude with research awards and a phytochemistry magic show by McGill University’s renowned chemistry guru, Dr. Joe Schwartz. The 2006 conference is again supported by Canada’s federal health agency, Health Canada, the U.S. Office of Dietary Supplements, and leading companies committed to NHP research. For further conference information and registration, please visit the NHPRS website at www.NHPresearch.bcit.ca or email NHPRS@bcit.ca. Media contact information: Dr. Allison McCutcheon, President ]Natural Health Product Research Society of Canada Phone 604-222-3488, fax 604-222-9613, email Allison@imag.net Registration is available online at: http://www.nhpresearch.bcit.ca/Toronto2006.html#Registration. Then click on the "Quick Enrollment" button to begin the registration process. You can register for both membership and the conference from this link.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software